Skip Links

11. Share capital

2008
Million
2007
Million
2008
£m
2007
£m
Authorised
Ordinary shares of 2 1/15p each 967.7 967.7 20.0 20.0
Allotted, called up and fully paid
Ordinary shares of 2 115 p each (pre 14 September 2007: ordinary shares of 2p each)
At 1 January – ordinary shares of 2 115 p each (2007: 2p each) 609.0 617.6 12.6 12.3
Shares repurchased – ordinary shares of 2p each (6.6) (0.1)
Issued on exercise of share options – ordinary shares of 2p each 7.9 0.2
Reduction in issued shares on consolidation – see below (20.0)
Issued on exercise of share options – ordinary shares of 2 115 p each 12.2 10.1 0.2 0.2
At 31 December ordinary shares of 2 115 p 621.2 609.0 12.8 12.6

Treasury shares

2008
Million
2007
Million
2008
£m
2007
£m
Ordinary shares of 2 115 p each
At 1 January
Shares repurchased – ordinary shares of 2 115 p each 10.4 0.2
Shares transferred to Capita Employee benefit trust – ordinary 2 115 p shares (10.4) (0.2)
At 31 December – ordinary shares of 2 115 p

Employee benefit trust shares

2008
Million
2007
Million
2008
£m
2007
£m
Ordinary shares of 2 115 p each
At 1 January
Shares transferred from treasury 10.4 0.2
At 31 December – ordinary shares of 2 115 p 10.4 0.2

In September 2007, the Company, by ordinary resolution, approved a share consolidation whereby shareholders on the register on 14 September 2007 exchanged 31 existing ordinary shares of 2p for 30 new ordinary shares of 2 115 p each. The effect of the share consolidation was to reduce the authorised share capital of the Company to 967,741,920 ordinary shares of 2 115 p each and to reduce the number of shares in issue by 20m.

During the year the Company repurchased 10.4m ordinary 2 115 p shares with an aggregate nominal value of £0.2m at a total cost of £68.4m for which it paid cash at an average cost per share of £6.58. These shares were cancelled.

During the year 12.2m ordinary 2 115 p shares with an aggregate nominal value of £0.2m were issued under share option schemes for a total consideration of £35.7m.

The Company has an unexpired authority to repurchase up to 10% of its issued share capital.